Published in Appl Microbiol on September 01, 1971
Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev (2000) 3.17
Unusual groups of Morganella ("Proteus") morganii isolated from clinical specimens: lysine-positive and ornithine-negative biogroups. J Clin Microbiol (1980) 3.02
Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate. Appl Microbiol (1972) 2.65
Comparative in vitro activity of three aminoglycosidic antibiotics: BB-K8, kanamycin, and gentamicin. Antimicrob Agents Chemother (1973) 1.91
Biotypes of Proteus rettgeri. J Clin Microbiol (1975) 1.86
Unusual Enterobacteriaceae: a Salmonella cubana that is urease positive. J Clin Microbiol (1975) 1.25
In vitro additive effect of polymxin B and rifampin against Serratia marcesen. Antimicrob Agents Chemother (1975) 1.07
Potentiation of the antibacterial effect of methenamine by acetohydroxamic acid. Antimicrob Agents Chemother (1974) 0.99
Evaluation of a Proteus rettgeri O-serotyping system for epidemiological investigation. J Clin Microbiol (1976) 0.97
Typing methods for Proteus rettgeri: comparison of biotype, antibiograms, serotype, and bacteriocin production. J Clin Microbiol (1978) 0.93
Application of O-serotyping in a study of Providencia rettgeri (Proteus rettgeri) isolated from human and nonhuman sources. J Clin Microbiol (1979) 0.87
Differences among Providencia species in their in vitro susceptibilities to five antibiotics. Antimicrob Agents Chemother (1980) 0.84
Cross-protection of mice provided by active and passive immunization against experimental infections with virulent Proteus rettgeri and Providencia bacteria. Infect Immun (1978) 0.80
A Case of Wound Infection with Providencia rettgeri and Coincident Gout in a Patient from Guam. Hawaii J Med Public Health (2015) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Characterization of a transfer factor associated with drug resistance in Salmonella typhimurium. Nature (1965) 11.07
Episome-mediated transfer of drug resistance in Enterobacteriaceae. II. Elimination of resistance factors with acridine dyes. J Bacteriol (1961) 8.57
The Biochemical and Serological Relationships of the Organisms of the Genus Proteus. J Bacteriol (1945) 6.07
Inactivation of the bactericidal activity of human serum by liquoid (sodium polyanetholsulfonate). Appl Microbiol (1969) 5.30
Biochemical classification of Proteus and Providence cultures. J Gen Microbiol (1955) 4.19
Identification of Enterobacteriaceae in the clinical microbiology laboratory. Appl Microbiol (1970) 2.65
Use of gentamicin in combinations with other antibiotics. J Infect Dis (1969) 2.37
Contamination of commercially packaged urinary catheter kits with the pseudomonad EO-1. N Engl J Med (1970) 2.29
Urinary tract infection in a male urological ward; with special reference to the mode of infection. Lancet (1957) 2.22
Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data. Appl Microbiol (1970) 2.21
Biochemical investigation of Providence strains and their relationship to the Proteus group. J Hyg (Lond) (1954) 2.18
Proposed standard agglutinating sera for typhoid and paratyphoid A and B fevers. Bull World Health Organ (1954) 2.13
Proteus infections in hospital. J Pathol Bacteriol (1954) 1.97
Surveillance of nosocomial infections in community hospitals. I. Surveillance methods, effectiveness, and initial results. J Infect Dis (1969) 1.80
Susceptibility of Pseudomonas aeruginosa to carbenicillin. Appl Microbiol (1970) 1.76
Metabolic variations of Proteus in the Memphis area and other geographical areas. Appl Microbiol (1968) 1.69
Biochemical characteristics of lactose-fermenting Proteus rettgeri from clinical specimens. J Bacteriol (1962) 1.68
The enterobacterial hemagglutination test and its diagnostic potentialities. Can J Microbiol (1956) 1.60
Infection and antibiotic usage at Boston City Hospital, January 1970. Arch Intern Med (1971) 1.55
Proteus mirabilis infections in a hospital nursery traced to a human carrier. N Engl J Med (1971) 1.30
Microtiter bacterial hemagglutination technique for detection of Shigella antibodies. J Bacteriol (1966) 1.29
HOSPITAL-ACQUIRED URINARY-TRACT INFECTIONS. Ann Intern Med (1964) 1.22
Rat pyelonephritis model suitable for primary or secondary screening. Appl Microbiol (1969) 1.21
Studies on the interaction between serum bactericidal activity and antibiotics in vitro. Chemotherapy (1970) 0.96
The causes of catheter-induced urinary infections and their prevention. J Urol (1969) 0.93
Urinary tract infections: correlation between organisms obtained simultaneously from the urine and feces of patients with bacteriuria and pyuria. J Urol (1969) 0.91
Isolation of an antibiotic-resistant, lactose-fermenting strain of Proteus rettgeri. Experientia (1970) 0.88
Hospital infection of the urinary tract with Proteus; a clinical-bacteriologic study with special reference to modes of infection. Acta Pathol Microbiol Scand (1958) 0.84
BACTERIOLOGICAL COMPLICATIONS FROM THE USE OF URETHRAL INSTRUMENTS: PRINCIPLES OF PREVENTION. J Clin Pathol (1964) 0.80
Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil (2012) 7.24
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Inactivation of the bactericidal activity of human serum by liquoid (sodium polyanetholsulfonate). Appl Microbiol (1969) 5.30
The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil (2014) 4.69
Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature (1998) 3.77
Antibacterial action of "broad-spectrum" penicillins, cephalosporins and other antibiotics against Gram-negative bacilli isolated from bacteremic patients. Ann N Y Acad Sci (1967) 3.17
Anticomplementary, anticoagulatory, and serum-protein precipitating activity of sodium polyanetholsulfonate. Appl Microbiol (1970) 2.96
Identification of a nonsense mutation in the carboxyl-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc Natl Acad Sci U S A (1996) 2.77
Identification of Enterobacteriaceae in the clinical microbiology laboratory. Appl Microbiol (1970) 2.65
Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate. Appl Microbiol (1972) 2.65
Evaluation of esophageal motor function in clinical practice. Neurogastroenterol Motil (2013) 2.54
Synergistic combinations of penicillins in the treatment of bacteriuria. N Engl J Med (1967) 2.53
Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family. Circ Res (1998) 2.49
Locus control region function and heterochromatin-induced position effect variegation. Science (1996) 2.42
Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet (1998) 2.34
Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data. Appl Microbiol (1970) 2.21
Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens. Appl Microbiol (1971) 2.19
Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients. Aliment Pharmacol Ther (2013) 2.17
Fatality rates and regulatory policies in bituminous coal mining, United States, 1959-1981. Am J Public Health (1983) 2.11
Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc Natl Acad Sci U S A (1980) 2.08
Molecular evolution of the human adult alpha-globin-like gene region: insertion and deletion of Alu family repeats and non-Alu DNA sequences. Proc Natl Acad Sci U S A (1983) 2.07
Opinion statement on the minimal acceptable standards of healthcare in cerebral palsy. Disabil Rehabil (2001) 2.05
The Chinese hamster HPRT gene: restriction map, sequence analysis, and multiplex PCR deletion screen. Genomics (1991) 2.03
Lincomycin: activity in vitro and absorption and excretion in normal young men. Am J Med Sci (1967) 2.00
Media-dependent antagonism of gentamicin sulfate by Liquoid (sodium polyanetholsulfonate). Experientia (1969) 1.99
Effects of baclofen on the functional anatomy of the oesophago-gastric junction and proximal stomach in healthy volunteers and patients with GERD assessed by magnetic resonance imaging and high-resolution manometry: a randomised controlled double-blind study. Aliment Pharmacol Ther (2014) 1.99
VY bipedicle flap for resurfacing the nasal supratip region. Plast Reconstr Surg (1989) 1.98
New biological activity following intravascular activation of the complement cascade. Nature (1974) 1.89
Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity. J Clin Invest (1972) 1.85
Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J Biol Chem (2000) 1.78
Antagonism of polymyxin B and kanamycin sulfate by Liquoid (sodium polyanetholsulfonate) in vitro. Experientia (1969) 1.77
Susceptibility of Pseudomonas aeruginosa to carbenicillin. Appl Microbiol (1970) 1.76
TAC use and absorption of cocaine in a pediatric emergency department. Ann Emerg Med (1990) 1.75
Fatal hepatoxicity secondary to nimesulide. Eur J Clin Pharmacol (2001) 1.72
Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem (1996) 1.66
Activity of lymphoid tissues from antilymphocyte-serum-treated mice. Lancet (1967) 1.66
Dissociation by colchicine of the hexose monophosphate shunt activation from the bactericidal activity of the leukocyte. Infect Immun (1971) 1.64
An isotopic assay for NADPH oxidase activity and some characteristics of the enzyme from human polymorphonuclear leukocytes. J Clin Invest (1975) 1.63
The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder. Am J Hum Genet (2000) 1.60
Superoxide dismutase activity in leukocytes. J Clin Invest (1974) 1.59
Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am J Hum Genet (2000) 1.58
The susceptibility of Clostridium perfringens type A to cephalosporin C antibiotics in vitro. Chemotherapy (1971) 1.58
1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants. Am J Pathol (1981) 1.56
Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest (1991) 1.54
Normative values and inter-observer agreement for liquid and solid bolus swallows in upright and supine positions as assessed by esophageal high-resolution manometry. Neurogastroenterol Motil (2011) 1.53
Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med (1969) 1.53
Physiology of the oesophageal transition zone in the presence of chronic bolus retention: studies using concurrent high resolution manometry and digital fluoroscopy. Neurogastroenterol Motil (2008) 1.52
Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest (1992) 1.50
Synergistic penicillin combinations for treatment of human urinary-tract infections. Antimicrob Agents Chemother (Bethesda) (1966) 1.48
A labile transcriptional repressor modulates endotoxin tolerance. J Exp Med (1994) 1.47
Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol (1986) 1.45
Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin. Chemotherapy (1985) 1.45
Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest (1980) 1.44
Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor. J Clin Invest (1986) 1.44
The reaction of oxidizing agents with wool. 1. The division of cystine into two fractions of widely differing reactivities. Biochem J (1950) 1.43
Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils. J Biol Chem (1989) 1.42
Functional characteristics of human toxic neutrophils. J Infect Dis (1971) 1.41
Coexistence of subacute cutaneous lupus erythematosus and porphyria cutanea tarda: a case report. Cutis (1995) 1.40
Heterochromatin protein 1 modifies mammalian PEV in a dose- and chromosomal-context-dependent manner. Nat Genet (1999) 1.40
Isolated latissimus dorsi transfer to restore shoulder external rotation in adults with brachial plexus injury. Bone Joint J (2013) 1.39
A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation (2000) 1.39
Idiopathic chronic urinary retention in the female. Br J Urol (1975) 1.38
Identification of sonic hedgehog as a candidate gene responsible for the polydactylous mouse mutant Sasquatch. Curr Biol (1999) 1.36
An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med (1982) 1.33
Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. J Biol Chem (1997) 1.32
Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing. Appl Microbiol (1971) 1.32
Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens. Chemotherapy (1984) 1.31
Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells. Mol Cell Biol (1998) 1.30
Characterization of a mucin cDNA clone isolated from HT-29 mucus-secreting cells. The 3' end of MUC5AC? J Biol Chem (1995) 1.29
Independent stimulation of motility and the oxidative metabolic burst of human polymorphonuclear leukocytes. J Immunol (1978) 1.27
Renal carcinoma in a living kidney graft donor. Transplantation (1973) 1.27
Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens. Chemotherapy (1975) 1.27
Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem (1992) 1.26
Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. Biochem Biophys Res Commun (1992) 1.25
Magnesium-dependent adenosine triphosphatase as a marker enzyme for the plasma membrane of human polymorphonuclear leukocytes. Infect Immun (1977) 1.25
Eosinopenia of acute infection: Production of eosinopenia by chemotactic factors of acute inflammation. J Clin Invest (1980) 1.24
Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. J Med Chem (1997) 1.24
Polymyxin B-induced cocarde growth phenomenon of Serratia marcescens due to cationic detergent-like activity of polymyxin B. Chemotherapy (1982) 1.22
Phagocytosis of live versus heat-killed bacteria by human polymorphonuclear leukocytes. Infect Immun (1974) 1.22
Evaluation of two spot-indole reagents. Appl Microbiol (1969) 1.22
Identification of staphylococci isolated from clinical material. Appl Microbiol (1970) 1.22
Characterization and chromosomal mapping of a genomic clone encoding human alanine:glyoxylate aminotransferase. Genomics (1991) 1.22
Characterization of the human interleukin 1 receptor on human polymorphonuclear leukocytes. Clin Immunol Immunopathol (1988) 1.20
The effects of ascorbic acid on bactericidal mechanisms of neutrophils. J Infect Dis (1971) 1.19
Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest (1990) 1.19
Efficiency of cultures of rectal swabs and faecal specimens in detecting salmonella carriers: correlation with numbers of salmonellas excreted. J Hyg (Lond) (1966) 1.18
Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens. Infect Immun (1976) 1.17
Priming of the respiratory burst of neutrophils by diacylglycerol. Independence from activation or translocation of protein kinase C. J Biol Chem (1987) 1.17
Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease. J Clin Invest (1988) 1.16
Selective desensitization of neutrophils: further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues. J Immunol (1981) 1.15
Serotyping of Serratia marcescens: evaluation of Le Minor's H-immobilization test and description of three new flagellar H antigens. J Clin Microbiol (1977) 1.13
The human homolog T of the mouse T(Brachyury) gene; gene structure, cDNA sequence, and assignment to chromosome 6q27. Genome Res (1996) 1.13
Ultrastructural surface alterations of serratia marcescens after exposure to polymyxin B and/or fresh human serum. Chemotherapy (1976) 1.12
Performance-based measurements among elderly drivers and nondrivers. J Am Geriatr Soc (1988) 1.12